Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
30 October 2021 - 7:36AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2021
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified in its
charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Extraordinary General Meeting Results
On October 29, 2021,
AC Immune SA (“AC Immune”) held an Extraordinary General Meeting. The press release relating to the results of the
extraordinary shareholders’ meeting is attached hereto as Exhibit 99.1.
The Board withdrew
Agenda Item 2.1 “Authorized Share Capital,” Agenda Item 2.2 “Conditional Capital Increase for Bonds and Similar Debt
Instruments” and Agenda Item 2.3 “Conditional Capital Increase for Employee Benefit Plans” prior to the Extraordinary
General Meeting.
The final results
of the remaining agenda items submitted to a vote of the shareholders is as follows:
Agenda Item 1: Elections to the Board
of Directors
Agenda Item 1.1: Election of Monica
Shaw as member of the Board of Directors
AC Immune shareholders
approved the election of Monica Shaw as a member of the Board of Directors until the end of the next Annual General Meeting.
Agenda Item 1.2: Election of Monika
Bütler as member of the Board of Directors
AC Immune shareholders
approved the election of Monika Bütler as a member of the Board of Directors until the end of the next Annual General Meeting.
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
AC IMMUNE SA
|
|
|
|
|
|
By:
|
/s/ Andrea Pfeifer
|
|
|
|
Name:
|
Andrea Pfeifer
|
|
|
|
Title:
|
Chief Executive Officer
|
|
|
By:
|
/s/ Joerg Hornstein
|
|
|
|
Name:
|
Joerg Hornstein
|
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
|
|
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
|
|
|
99.1
|
Press Release dated October 29, 2021
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Apr 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2023 to Apr 2024
